Japan has approved two pioneering stem-cell therapies for the treatment of Parkinson’s disease and severe heart failure, marking a major milestone in regenerative medicine. The therapies are expected to reach patients within months, according to manufacturers and media reports. Pharmaceutical company Sumitomo Pharma said it received approval to manufacture and sell Amchepry, a treatment for […]